Hepatic amino acids (HAA)

Hepatic amino acids refer to the collective pool of amino acid molecules within the liver that serve as the primary substrates for protein synthesis, gluconeogenesis, and the urea cycle. The liver acts as the central hub for amino acid metabolism, regulating the systemic distribution of nitrogen and the detoxification of ammonia into urea (Source: StatPearls, 'Physiology, Liver'). In various disease states, particularly chronic liver failure and cirrhosis, the composition of this pool is significantly altered, often characterized by a decrease in branched-chain amino acids (BCAAs) and an increase in aromatic amino acids (AAAs) (Source: NIH, PubMed PMC6724422). While not a single protein target such as a receptor or enzyme, the hepatic amino acid pool is a critical focus for clinical intervention; for example, BCAA supplementation is used to manage hepatic encephalopathy by competing with AAAs for transport across the blood-brain barrier and supporting muscle-based ammonia detoxification (Source: PubMed, PMID: 24703120). Furthermore, understanding the flux of these metabolites is essential for treating metabolic disorders and optimizing nutritional support in critically ill patients.

Other names

Liver amino acidsIntrahepatic amino acid poolHepatic amino acid metabolismHepatic nitrogenous metabolites

Therapeutic interventions involving hepatic amino acids typically function by either supplementing depleted essential amino acids (such as branched-chain amino acids to improve nitrogen balance and signaling) or by utilizing nitrogen-scavenging agents to remove excess ammonia generated from amino acid catabolism.